Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
3.14M
-
Shares change
-
-1.03M
-
Total reported value, excl. options
-
$1.66M
-
Value change
-
-$1.13M
-
Put/Call ratio
-
0.33
-
Number of buys
-
15
-
Number of sells
-
-3
-
Price
-
$0.53
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2022
30 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q2 2022.
IGC Pharma, Inc. - COM NEW (IGC) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.14M shares
.
Largest 10 shareholders include BlackRock Inc. (744K shares), VANGUARD GROUP INC (646K shares), GEODE CAPITAL MANAGEMENT, LLC (303K shares), RENAISSANCE TECHNOLOGIES LLC (218K shares), STATE STREET CORP (184K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (178K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (139K shares), CITADEL ADVISORS LLC (128K shares), DEARBORN PARTNERS LLC (125K shares), and Vident Investment Advisory, LLC (108K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.